FDA Dissolution Methods

The FDA Dissolution Methods Database is a public reference resource mAIntained by the U.S. Food and Drug Administration's Center for Drug evaluation and research. It collects recommended in vitro dissolution Testing methods and experimental conditions for a wIDE range of drug products, giving fORMulation scientists, quality control teams, and regulatory specialists a single place to look up established testing parameters.

What it does

The database lets users search and retrieve dissolution method entries for specific drug products. Each record typically describes the recommended APParatus, medium, volume, rotation or flow rate, Sampling times, and related analytical conditions. Because these are regulatory reference methods, the database functions primarily as a lookup and documentation tool rather than a generative or interACTive AI application.

Key capabilities

• Searchable index of drug products with associated dissolution method details
• Reference to apparatus type and operating conditions for in vitro testing
• Support for method selection and Comparison during development and quality control
• Publicly accessible data drawn from FDA review and guidance activity
• Useful for aligning internal laboratory methods with regulatory expectations

Who it is for

This resource is most relevant to phArmaceutical R&D scientists, analytical chemists, quality assurance and quality control staff, contract research and manufacturing organizations, and regulatory affairs Professionals. academic researchers and students studying biopharmaceutics or dosage form performance may also find it useful when designing dissolution experiments or reviewing case studies.

How to get started

Access the database through the FDA's public website and browse or search for your drug product of interest. Review the listed method conditions carefully against your own formulation and compendial requirements. Many teams export or note records for internal method development documents. Results may be updated over time, so confirm you are viewing the latest available entry before relying on a method for regulatory submissions.

Pricing and access caveat

The database is offered at no cost as a public regulatory resource and does not require a subscription. Availability, coveRAGe of specific products, and the exact fields shown may vary and are subject to change by the FDA. The database should be treated as reference Information, not a substitute for official guidance, pharmacopeial Standards, or professional regulatory advice.